Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Daiichi Sankyo Company Limited
Daiichi Sankyo Company Limited_20100107
Daiichi Sankyo Company Limited_20100121
Daiichi Sankyo Company Limited_20100114

Daiichi Sankyo Company Limited patents

Recent patent applications related to Daiichi Sankyo Company Limited. Daiichi Sankyo Company Limited is listed as an Agent/Assignee. Note: Daiichi Sankyo Company Limited may have other listings under different names/spellings. We're not affiliated with Daiichi Sankyo Company Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Daiichi Sankyo Company Limited-related inventors

Date Daiichi Sankyo Company Limited patents (updated weekly) - BOOKMARK this page
10/12/17 new patent  Method for producing optically active valeric acid derivative
10/12/17 new patent  Salt of dicarboxylic acid compound
10/05/17Algorithms for gene signature-based predictor of sensitivity to mdm2 inhibitors
09/28/17Pharmaceutical composition having abuse deterrent properties
09/14/17Sustained-release pharmaceutical composition for treatment and prevention of eye disease
09/14/17Polynucleotides and polypeptide sequences involved in the process of bone remodeling
08/24/17Pyridine compounds
08/17/17Crystal of pyrrole derivative and producing the same
08/10/17Anti-orai1 antibody
08/10/17Human anti-fgfr4 antibody
08/03/17Method for treating cancer by combined use
07/27/17Pyridine compounds
07/27/17Method for improved high-level secretory production of protein
06/29/17Pyridone derivative having tetrahydropyranylmethyl group
06/22/17Tricyclic benzoxaboroles as antibacterial agents
06/08/17Method for producing spirooxindole derivative
05/11/17Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfecta
04/27/17Method for manufacturing neuraminic acid derivatives
04/20/17Aminopyrazolone derivative
03/23/17Medicine against growth failure induced by administration of steroid
03/23/17Crystals of dispiropyrrolidine derivatives
03/23/17Crystals of dispiropyrrolidine derivatives
03/23/17Crystals of dispiropyrrolidine derivatives
03/23/17Crystals of dispiropyrrolidine derivatives
03/16/171,3-benzodioxole derivative
03/09/17Method for predicting responsiveness to cancer treatment using p300-inhibiting compound
03/02/17Crystal of pyrrole derivative and producing the same
02/23/17Method for producing inhibitor of activated blood coagulation factor x (fxa)
02/09/17(anti-her2 antibody)-drug conjugate
01/26/17Anti-her3 antibody-drug conjugate
01/26/17High-purity crystals of active blood coagulation factor x (fxa) inhibitor
01/19/17Dicarboxylic acid compound
01/05/17Cycloalkane derivatives
12/29/165-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative
12/22/16Anti b7-h3 antibody
11/17/16Anti-her2 antibody-drug conjugate
11/17/16Dna element having the activity of enhancing foreign gene expression
11/17/16Gene signatures associated with sensitivity to mdm2 inhibitors
11/10/16Adjuvant for mucosal vaccine
11/10/16Synthesis of a compound that modulates kinases
11/03/16Combination of anti-fgfr2 antibody and other agent
10/27/16Anti-lps o11 antibody
10/13/16Terpenoid derivatives
10/13/16Anti-trop2 antibody-drug conjugate
09/29/16Antibody-drug conjugate
09/08/16Novel lipid
08/25/16Crystals of dispiropyrrolidine derivatives
08/18/16Method for producing pyrrole derivative, and intermediate thereof
08/11/16Selective production d-mannitol alpha-form crystal using spray-drying method
07/21/16Pharmaceutical for prophylaxis or treatment of hypertension
07/21/16Complex containing oligonucleotide having immunopotentiating activity and use thereof
07/07/16Method for producing spirooxindole derivative
06/16/16Method for purifying oligosaccharide peptide
06/16/16Method for investigation of liver damage type
05/19/16Method for producing tricyclic heterocyclic compound
05/12/16Method for preventing influenza virus infection by administering a dry powder pharmaceutical composition
05/12/16Solid dosage form of olmesartan medoxomil and amlodipine
05/12/16Method for predicting response to cancer treatment
04/21/16Anti-robo4 antibody
04/14/16Acetone solvate crystals of trityl omesartan medoxomil
04/07/16Crystal of pyrrole derivative and producing the same
03/31/16Substituted phenylazole derivative
03/24/16Substituted phenylazole derivative
03/10/16Intermediate for production of nucleoside analog and producing the same
Patent Packs
03/10/16Novel anti-dr5 antibody
03/03/16Formulation for treating equine inflammation
02/25/16Method for manufacturing neuraminic acid derivatives
02/18/16Dicarboxylic acid compound
02/18/16Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors
02/11/16Drug for respiratory diseases
02/04/16Anti-epha2 antibody
01/28/16Benzothiophene derivative
01/21/16Preparation optically active diamine compound
01/21/16Glyco-modified atrial natriuretic peptide
01/14/16Anti-fgfr2 antibody
01/14/16Method for predicting responsiveness to compound inhibiting mapk signal transduction pathway
01/07/16Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors
12/31/15Method for manufacturing neuraminic acid derivatives
12/31/15Neuraminic acid derivatives
Patent Packs
12/24/15Sustained-release solid preparation for oral use
12/24/15Method of constructing masses of myocardial cells and use of the myocardial cell mass
12/10/15Antibody-drug conjugate produced by binding through linker having hydrophilic structure
12/10/15Method for producing (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
12/10/15Mait-like cells and manufacturing same
12/03/15Pharmaceutical composition
12/03/15Antibody targeting osteoclast-related protein siglec-15
11/12/15Method for measuring thrombin generation
10/29/15Adjuvant for mucosal vaccine
10/22/15Antibody-drug conjugate
10/22/15Acid addition salt of substituted pyridine compound
10/22/15Anti-siglec-15 antibody
10/01/15Use of a factor xa inhibitor for treating and preventing bleeding events and related disorders in patients having sensitivity to vitamin k antagonists used as anticoagulants
09/24/15Therapeutic agent for amyotrophic lateral sclerosis
09/17/15Method for manufacturing neuraminic acid derivatives
08/27/15Therapeutic agent for hyperthermia
08/27/15Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
08/20/15Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
08/06/15Cyclopropanecarboxylic acid derivative
08/06/15Preparation optically active bicyclic gamma-amino acid compound
07/30/15Crystals of dispiropyrrolidine derivatives
07/16/15Peptide library and use thereof
06/11/15Heterocyclic compounds as protein kinase inhibitors
06/04/15Piperidinylpyrazolopyridine derivative
06/04/15Intermediate for production of nucleoside analog and producing the same
06/04/15Nucleic acid biomarker and use thereof
05/28/15Protein biomarker and uses thereof
05/21/15Tablet dispensing and managing container
05/07/15Anti-fgfr2 antibody
05/07/15Bone repair promoter
Social Network Patent Pack
05/07/15Novel anti-siglec-15 antibody
04/23/15Orally disintegrating tablet and production process therefor
04/09/15Anti-robo4 antibody
03/19/15Solid compositions comprising a salt of aminocarboxylic acid
03/05/15Agent for treatment and prevention of cancer
02/26/15Cdr-modified anti-siglec-15 antibody
02/19/15Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors
02/05/15Optical resolution methods for bicyclic compounds using enzymes
01/15/15Cycloalkane derivatives
01/08/15Tablet, producing tablet, tablet management device, tablet verification device and program storage medium
Patent Packs
01/08/154-alkanoylamino-3-pyrazolone derivative
01/08/15(2-heteroarylamino) succinic acid derivatives
12/18/14Crystal of a free tricyclic pyrazolopyrimidine derivative
12/18/14Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment
12/18/14Process for production of quinuclidine compounds
12/04/14Substituted phenylazole derivatives
11/27/14Chromone derivative having osteogenesis promoting effect
11/20/14Promoter derived from human gene
11/20/14Phenylxanthene derivatives
10/02/14Optical resolution bicyclic compound using asymmetric catalyst
08/07/14Cyclohexane derivative compound
08/07/14Cyclohexane derivative compound
08/07/14Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
08/07/14N-hetero-ring-substituted amide derivative
07/31/14Anti-epha2 antibody
07/31/14Substituted pyridine compound
07/03/14Amino group-containing pyrrolidinone derivative
07/03/14Nitrogen-containing aromatic heterocyclyl compound
06/26/14Cycloalkyl-substituted imidazole derivative
06/19/14Pharmaceutical composition containing diamine derivative
06/05/14Heterocyclic compounds as protein kinase inhibitors
05/22/14Fused substituted aminopyrrolidine derivative
05/15/14Phosphoric acid ester derivatives
05/15/14Product quality control method
05/01/14Dispiropyrrolidine derivatives
05/01/14Crystals of phenylpyrrole derivative
04/10/14Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment
04/03/14Method for producing bicyclic compound via claisen rearrangement
04/03/14Method for producing bicyclic compound via iminium salt
03/20/14Tetrahydrothiazepine derivative
Patent Packs
03/13/14Sustained-release solid preparation for oral use
03/13/14Imidazole carbonyl compound
03/13/14Dipyridylamine derivative
03/13/14Crystals of substituted cycloalkene derivatives
03/13/14Thienopyrazole derivative having pde7 inhibitory activity
03/06/14Anti-siglec-15 antibody
02/20/14Dissolution properties of drug products containing olmesartan medoxomil
02/13/14Cycloalkane derivatives
01/23/14Atropisomer of pyrrole derivative
01/16/14Method for manufacturing neuraminic acid derivatives
01/16/14Methods of treating or preventing h5n1 influenza
01/09/14Novel antibodies and uses thereof
01/02/14Novel anti-dr5 antibody
12/26/13Method for production of prasugrel hydrochloride having high purity
12/19/13Pharmaceutical composition
12/19/13Imidazopyridin-2-one derivatives
12/19/13Crystal of anti-bacterial compound
11/28/13Peptide library
10/24/13Antibody targeting osteoclast-related protein siglec-15
09/26/13Method of producing a solid preparation
Social Network Patent Pack
09/26/13Modified single-stranded polynucleotide
09/05/13Cycloalkyl-substituted imidazole derivative
08/22/13Acylbenzene derivative
08/15/13Free crystal of tricyclic pyrazolopyrimidine derivative
08/08/13Crystal of tricyclic pyrazolopyrimidine derivative
08/08/13Process for preparing benzoic acid esters
07/18/13Method of treating cancers and a pharmaceutical composition that may be used in practicing said method
07/18/13Activated blood coagulation factor x (fxa) inhibitor
07/11/13Crystals of substituted cycloalkene derivatives
07/04/13Dna element having the activity of enhancing foreign gene expression
07/04/13Imidazothiazole derivatives having proline ring structure
06/27/13Process for preparation of optically active diamine derivative salt
06/20/13Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment
06/06/13Process for preparing a compound by a novel sandmeyer-like reaction using a nitroxide radical compound as a reaction catalyst
05/30/13Crystal of anti-bacterial compound
05/02/13Substituted pyridine compound
04/25/13Method for screening for s1p lyase inhibitors using cultured cells
03/28/13Anti b7-h3 antibody
03/07/13Process for production of quinuclidine compounds
02/21/13Pyridine derivative
Social Network Patent Pack
02/07/13Fused bicyclic heteroaryl derivative
02/07/13Crystal of diamine derivative and producing same
01/31/13[5, 6] heterocyclic compound
01/31/13Fused substituted aminopyrrolidine derivative
01/24/13Cycloalkyl-substituted imidazole derivative
01/24/13Method for improving dissolution of anticoagulant agent
01/10/13Composition for nasal administration and preparing same
01/10/13Cyclopropanecarboxylic acid derivative
01/10/13Sustained-release solid preparation for oral use
01/03/13Sustained-release solid preparation for oral use
01/03/13Sustained-release solid preparation for oral use
01/03/13Method for proliferating cardiomyocytes using micro-rna
12/13/12Imidazole derivative
11/29/12Method for improving cerebral circulation or treating a cerebral blood flow disorder
10/18/12Method of treating cancers and a pharmaceutical composition that may be used in practicing said method
10/18/12Medical compositions containing ghrelin
10/11/12Seven-membered ring compound and pharmaceutical use therefor
10/11/12Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
10/11/12Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/11/12Method of treating a cancer by administering a specified drug
10/04/12Antibody targeting osteoclast-related protein siglec-15
09/27/123-(biaryoxy)propionic acid derivative
09/20/12Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method
09/13/12Antibody targeting osteoclast-related protein siglec-15
08/30/12Substituted acrylamide derivative and pharmaceutical composition comprising the same
08/30/125-hydroxypyrimidine-4-carboxamide derivative
08/30/12Modified double-stranded polynucleotide
08/09/12Tricyclic pyrazolopyrimidine derivatives
07/05/12Method for producing asymmetric tetrasubstituted carbon atom-containing compound
06/21/12Vla-4 inhibitory drug
Social Network Patent Pack
05/24/12Motilin-like peptide compound having transmucosal absorbability imparted thereto
05/24/12Amide derivative
05/24/12Sulfone derivative
05/10/12Pharmaceutical composition having improved solubility
05/03/12Fused substituted aminopyrrolidine derivative
05/03/12Nitrogen-containing aromatic heterocyclyl compound
04/19/12Methods for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes
03/29/12Method for producing a solid preparation
03/22/12Amide derivative
03/22/12Morpholinopurine derivatives
03/22/12Method for producing olmesartan medoxomil
03/22/12Method for producing bicyclic gamma-amino acid derivative
03/15/12Dissolution properties of drug products containing olmesartan medoxomil
03/08/12Novel solvate crystals
03/08/12Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
03/01/12Oxamide derivative
02/23/12Method for inhibiting the induction and formation of osteoclasts
02/16/12Cyclic compound having substituted phenyl group
02/16/12Process for producing diamine derivative
02/09/12Anti-mst1r antibodies and uses thereof
02/09/12Method for producing optically active diamine derivative
02/02/12Pyridine derivative
12/29/11Indanyl compounds
12/29/11Cyclic amine compounds
12/22/11Diamine derivatives
12/22/11Activated blood coagulation factor inhibitor
11/17/11Pharmaceutical preparation containing an angiotensin ii receptor antagonist, a calcium channel blocker and polyvinyl alcohol
11/10/11Activated blood coagulation factor x (fxa) inhibitor
11/10/11Method for producing diamine derivative

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Daiichi Sankyo Company Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Daiichi Sankyo Company Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by